Richiedi info sul prodotto
Information on returns and shipments
Payment methods
Painful and inflammatory conditions of a rheumatic or traumatic nature of the joints, muscles, tendons and ligaments.
Ilmodol pain and inflammation 1% cutaneous foam is a non-steroidal anti-inflammatory and antirheumatic drug.
100 grams of solution contain: active ingredient: piroxicam 1 g.
Propylene glycol, hydrochloric acid, sodium hydroxide, sodium phosphate monobasic monohydrate, nicotinamide, polysorbate 80, povidone, ethyl alcohol, benzyl alcohol, lavender essence, nerolene essence, purified water.
Propellant: propane-butane-isobutane.
Adults: Apply 3-5 cm of foam or more to the skin 2-3 times a day, depending on the size of the affected area, massaging gently to promote absorption.
Ilmodol pain and inflammation 1% skin foam: Remove the protective cap; dispense the foam on the affected area and close it again.
The quantity of active ingredient absorbed through the skin does not normally reach concentrations in the circulation sufficient to validate the warnings and expose to the risk of side effects related to systemic administration of the drug.
The application of products for topical use, especially if prolonged, can cause serious side effects. give rise to sensitization phenomena.
In the event of hypersensitivity reactions, treatment should be discontinued and appropriate therapy should be instituted.
Serious skin reactions, some of which are life-threatening, such as exfoliative dermatitis, Stevens-Johnson syndrome (SJS), and toxic epidermal necrolysis (TEN), have been reported with the use of systemic piroxicam.
These reactions have not been associated with topical piroxicam, however, the possibility that they may occur with topical administration cannot be excluded.
Patients should be informed of the signs and symptoms and should be carefully monitored for skin reactions.
The most common side effects are: The high risk of developing SJS and TENS occurs in the first weeks of treatment.
If symptoms and signs of SJS or TENS occur (e.g., progressive skin rash often with blisters or mucosal lesions), treatment with piroxicam should be discontinued.
The best results in the management of SJS and TENS are achieved with early diagnosis and immediate discontinuation of therapy with any suspect drug.
Early discontinuation is associated with a better prognosis.
If the patient has developed SJS or TENS with the use of ilmodol pain and inflammation, the drug should no longer be used. reused in this patient.
Nonsteroidal anti-inflammatory drugs, including piroxicam, can cause interstitial nephritis, nephrotic syndrome, and renal failure.
There have also been reports of interstitial nephritis, nephrotic syndrome, and renal failure with topical piroxicam, although a causal relationship with treatment with topical piroxicam has not been established.
Therefore, no specific recommendations can be made. exclude that these adverse events may be related to the use of topical piroxicam.
Hypersensitivity to the active substance or to any of the excipients.
Based on bioavailability studies, it is extremely unlikely that piroxicam foam displaces other drugs bound to plasma proteins.
However, physicians should monitor patients treated with ilmodol pain and inflammation foam and highly protein-bound drugs for possible dosage adjustments.
Like all medicines, ilmodol pain and inflammation can cause side effects, although not everybody gets them.
Use of the product, especially if prolonged, may cause side effects. give rise to sensitization and local irritation phenomena.
Skin and subcutaneous tissue disorders.
Rare: urticaria (immediate reaction)*; very rare: bullous reactions such as Stevens-Johnson syndrome and toxic epidermal necrolysis; Not known (frequency cannot be estimated from the available data): contact dermatitis, eczema and photosensitivity skin reactions.
Respiratory, thoracic and mediastinal disorders.
Rare: bronchospasm (immediate reaction)*.
(*) in this case treatment should be discontinued.
Reporting of suspected adverse reactions.
Reporting suspected adverse reactions that occur after authorisation of the medicinal product is important, as it allows continued monitoring of the benefit/risk balance of the medicinal product.
No cases of overdose have been reported in the literature to date.
Fertility: Based on the mechanism of action, the use of NSAIDs, including piroxicam, may increase the risk of conception. delay or prevent the rupture of ovarian follicles, which has been associated with reversible infertility in some women.
In women with difficulties conceiving or undergoing investigation for infertility, the discontinuation of NSAIDs, including piroxicam, should be considered.
Pregnancy: The amount of active ingredient absorbed through the skin does not normally reach concentrations in the circulation sufficient to validate the warnings and expose to the risk of adverse effects related to systemic administration of the drug.
However, as a precaution, unless the doctor considers it absolutely necessary, its use during pregnancy is not recommended.
The inhibition of prostaglandin synthesis may adversely affect pregnancy.
Data obtained from epidemiological studies suggest an increased risk of spontaneous abortion after the use of prostaglandin synthesis inhibitors in the early stages of pregnancy.
In In animals, the administration of prostaglandin synthesis inhibitors has been shown to cause an increase in pre- and post-implantation loss.
Breastfeeding: The use of topical piroxicam during breastfeeding is not recommended as its clinical safety has not been evaluated.
Ilmodol pain and inflammation 1% skin foam: The pressurized container must not be punctured, it must not be brought close to heat sources, even when empty, do not freeze and protect the medicine from direct sunlight.
Do not expose to temperatures above 50 degrees C.
50 g tube
This product has been on sale since 21/01/2022
In the last 30 days, the product's lowest price was 10,76 €
Estimated delivery: 1-3 business days
Estimated delivery: 1-3 business days
Estimated delivery: 1-3 business days
Estimated delivery: 1-3 business days
